On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...
If you’re in pain and you’re looking for relief in the form of an over-the-counter drug, you’ve got a slew of options.
A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...
The Food and Drug Administration announced the approval of a new non-opioid pain medication this week, marking the first time ...
Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...
People undergoing hemodialysis treatment for kidney failure often experience chronic pain related to their condition, but it ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain for adults.
It’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the ...